Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 126
Filter
1.
Intern Emerg Med ; 12(2): 157-162, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27562379

ABSTRACT

Little research focuses on the association between immune thrombocytopenic purpura and human immunodeficiency virus infection in Taiwan. This study investigated whether immune thrombocytopenic purpura might be an early hematologic manifestation of undiagnosed human immunodeficiency virus infection in Taiwan. We conducted a retrospective population-based cohort study using data of individuals enrolled in Taiwan National Health Insurance Program. There were 5472 subjects aged 1-84 years with a new diagnosis of immune thrombocytopenic purpura as the purpura group since 1998-2010 and 21,887 sex-matched and age-matched, randomly selected subjects without immune thrombocytopenic purpura as the non-purpura group. The incidence of human immunodeficiency virus infection at the end of 2011 was measured in both groups. We used the multivariable Cox proportional hazards regression model to measure the hazard ratio and 95 % confidence interval (CI) for the association between immune thrombocytopenic purpura and human immunodeficiency virus infection. The overall incidence of human immunodeficiency virus infection was 6.47-fold higher in the purpura group than that in the non-purpura group (3.78 vs. 0.58 per 10,000 person-years, 95 % CI 5.83-7.18). After controlling for potential confounding factors, the adjusted HR of human immunodeficiency virus infection was 6.3 (95 % CI 2.58-15.4) for the purpura group, as compared with the non-purpura group. We conclude that individuals with immune thrombocytopenic purpura are 6.47-fold more likely to have human immunodeficiency virus infection than those without immune thrombocytopenic purpura. We suggest not all patients, but only those who have risk factors for human immunodeficiency virus infection should receive testing for undiagnosed human immunodeficiency virus infection when they develop immune thrombocytopenic purpura.


Subject(s)
AIDS-Related Complex/epidemiology , HIV Infections/epidemiology , Purpura, Thrombocytopenic, Idiopathic/epidemiology , Purpura, Thrombocytopenic, Idiopathic/virology , AIDS-Related Complex/virology , Adolescent , Adult , Aged , Aged, 80 and over , Causality , Child , Child, Preschool , Comorbidity , Female , Humans , Infant , Male , Middle Aged , Risk Assessment , Sex Distribution , Taiwan/epidemiology , Young Adult
3.
HIV Med ; 14(3): 182-6, 2013 Mar.
Article in English | MEDLINE | ID: mdl-22805116

ABSTRACT

OBJECTIVES: The aim of the study was to determine the aetiology and clinical predictors of peripheral lymphadenopathy in HIV-infected individuals during the antiretroviral (ARV) era in a nontuberculosis endemic setting. METHODS: A multicentred, retrospective cohort study of peripheral lymph node biopsies in HIV-positive adults was carried out. A total of 107 charts were identified and reviewed for clinical features, lymphadenopathy size, and ARV use and duration. Biopsy results were categorized, and multivariate logistic regression determined independent predictors of lymphadenopathy aetiology. RESULTS: Evaluation of 107 peripheral lymph node biopsies revealed that 42.9% of peripheral lymphadenopathy was attributable to malignancy, 49.5% to reactive changes, and 7.5% to infections, with only 2.8% of all cases secondary to tuberculosis. Fevers, weight loss, ARV use, and lower viral loads are significantly associated with nonreactive lymphadenopathy. CONCLUSIONS: Lymphadenopathy is likely to be reactive or malignant in nontuberculosis endemic regions. Readily available clinical features can aid clinicians in predicting the underlying aetiology, those at risk for malignancy, and who to biopsy.


Subject(s)
AIDS-Related Complex/etiology , AIDS-Related Opportunistic Infections/etiology , Acquired Immunodeficiency Syndrome/complications , HIV Seropositivity/complications , Lymph Nodes/pathology , Lymphatic Diseases/etiology , AIDS-Related Complex/epidemiology , AIDS-Related Complex/pathology , AIDS-Related Opportunistic Infections/epidemiology , AIDS-Related Opportunistic Infections/pathology , Acquired Immunodeficiency Syndrome/epidemiology , Acquired Immunodeficiency Syndrome/pathology , Adult , Biopsy , Boston/epidemiology , CD4 Lymphocyte Count , Cohort Studies , Female , HIV Seropositivity/epidemiology , HIV Seropositivity/pathology , Humans , Logistic Models , Lymphatic Diseases/pathology , Lymphoma, Non-Hodgkin/epidemiology , Male , Middle Aged , Mycobacterium avium-intracellulare Infection/epidemiology , Retrospective Studies , Sarcoma, Kaposi/epidemiology , Syphilis/epidemiology , Tuberculosis, Lymph Node/epidemiology , Viral Load
4.
S Afr Med J ; 100(4): 243-6, 2010 Mar 30.
Article in English | MEDLINE | ID: mdl-20459972

ABSTRACT

The practice of general surgery in a prison population differs considerably from that in a general surgical practice. We audited surgical consultations at the Mangaung Correctional Centre from December 2003 to April 2009. We found a high incidence of foreign object ingestion and anal pathology. Understanding the medical and social aspects of prison life facilitates the treatment of inmates with surgical problems.


Subject(s)
Anus Diseases/surgery , Foreign Bodies/surgery , Prisoners/statistics & numerical data , Surgical Procedures, Operative/statistics & numerical data , AIDS-Related Complex/epidemiology , AIDS-Related Complex/surgery , Anus Diseases/epidemiology , Delivery of Health Care , Feeding and Eating Disorders , Foreign Bodies/diagnostic imaging , Foreign Bodies/epidemiology , Humans , Male , Prisons , Radiography , Referral and Consultation/statistics & numerical data , Security Measures , Upper Gastrointestinal Tract/surgery
5.
Curr HIV Res ; 7(4): 365-77, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19601771

ABSTRACT

The spectrum of complications emerging in successfully treated HIV-infected patients has dramatically changed since the advent of HAART. Typical AIDS-defining illnesses have been substituted by new comorbid conditions that threaten even those patients who maintain virologic suppression. Proper management of cardiovascular risk, and early diagnosis of AIDS-related and, particularly, non-AIDS-related malignancies (including papilomavirus-related neoplasms) must be introduced into the routine of care. Hot areas of investigation include HIV-associated neurocognitive disorders, hepatitis B and C coinfection, non-alcoholic fatty liver disease, progressive multifocal leukoencephalopathy and tuberculosis. Bone and kidney long-term toxicities and lipoatrophy remain as issues of paramount importance. The identification and early treatment of immune reconstitution disease is also of major interest, specially in those patients starting their antiretroviral treatment with severe CD4 cell depletion. The present review focuses on these twelve areas of increasing interest for physicians currently facing successfully treated HIV+ patients.


Subject(s)
Acquired Immunodeficiency Syndrome/complications , Acquired Immunodeficiency Syndrome/drug therapy , Anti-HIV Agents/therapeutic use , Antiretroviral Therapy, Highly Active/methods , AIDS-Related Complex/epidemiology , AIDS-Related Complex/therapy , AIDS-Related Opportunistic Infections/epidemiology , AIDS-Related Opportunistic Infections/therapy , Acquired Immunodeficiency Syndrome/epidemiology , Cardiovascular Diseases/epidemiology , Cardiovascular Diseases/therapy , HIV-Associated Lipodystrophy Syndrome/epidemiology , HIV-Associated Lipodystrophy Syndrome/therapy , Humans , Immune Reconstitution Inflammatory Syndrome/therapy , Lymphoma, AIDS-Related/epidemiology , Lymphoma, AIDS-Related/therapy , Neoplasms/epidemiology , Neoplasms/therapy
6.
Gac. sanit. (Barc., Ed. impr.) ; 22(6): 511-519, nov.-dic. 2008. tab
Article in Spanish | IBECS | ID: ibc-61239

ABSTRACT

Objetivo: Describir los comportamientos y prácticas sexualesde adolescentes y jóvenes españoles en función del género.Método: La información fue recogida mediante un cuestionario,realizado en el domicilio de los participantes y con presenciadel entrevistador, aplicado a una muestra aleatoria integradapor 2.171 chicos y chicas de 14-24 años de edad,representativa de las comunidades de Galicia, Madrid y Andalucía.Resultados: Un total de 1.439 sujetos (66,3%) refirieron habertenido actividad sexual en los últimos 6 meses, sin apreciarsediferencias estadísticamente significativas entre chicos(66,4%) y chicas (66,2%), excepto en las siguientes variables:haber practicado el coito anal (los chicos refieren haberlo practicadoen mayor proporción); número de parejas sexuales (laschicas manifestaron tener menor número de parejas), y frecuenciade coitos vaginales (las chicas presentaron una frecuenciamás elevada en esta práctica). También se encontrarondiferencias en frecuencia de uso del condón en lasprácticas coito-anales y en las bucogenitales, en las que loschicos refirieron utilizarlo más frecuentemente.Conclusiones: Los datos de este estudio indican que los chicosy las chicas mantienen comportamientos sexuales diferenciados.En este sentido, las chicas suelen tener menor númerode parejas sexuales y utilizan el preservativo en mayormedida que los chicos en las prácticas coito-vaginales; sin embargo,hacen menor uso de éste en las prácticas bucogenitalesy coito-anales. En función de estos datos consideramosnecesario tener en cuenta la variable género a la hora de diseñare implementar intervenciones preventivas(AU)


Objectives: To describe the sexual behaviors and practicesof Spanish adolescents and young adults according to gender.Method: Information was gathered by means of a questionnaireadministered in participants’ homes in the presence ofan interviewer. A random sample was used, consisting of 2,171adolescents and young adults of both sexes, ranging in agefrom 14 to 24 years old. The participants were from three distinctregions of Spain: Galicia, Madrid, and Andalusia.Results: A total of 1,439 participants (66.3%) reported havingbeen sexually active in the previous 6 months, with nostatistically significant differences between male (66.4%) andfemale (66.2%) respondents. However, significant differenceswere found between males and females in the following variables:anal intercourse was reported by a higher proportionof males than females, the number of sexual partners reportedby females was lower than that reported by males and thefrequency of vaginal intercourse reported by females was higherthan that reported by males. Condom use in anal intercourseand oral sex was more frequently reported by malesthan by females.Conclusions: The results of this study indicate that sexualbehavior differs between genders, with females having a lowernumber of sexual partners and more frequently using a condomin vaginal intercourse but less frequently in oral sex andanal intercourse. In view of these data, we believe that gendershould be taken into account when designing and implementingpreventive interventions(AU)


Subject(s)
Humans , Male , Female , Adolescent , Adult , Sexuality/psychology , Sexuality/statistics & numerical data , Sex , Sexual Behavior/statistics & numerical data , Health Knowledge, Attitudes, Practice , AIDS-Related Complex/prevention & control , Acquired Immunodeficiency Syndrome/epidemiology , Acquired Immunodeficiency Syndrome/prevention & control , Condoms/statistics & numerical data , Condoms/trends , Surveys and Questionnaires/standards , Condoms , AIDS-Related Complex/epidemiology , Sexuality/physiology , Surveys and Questionnaires , Condoms/economics , Condoms/standards
7.
Rinsho Shinkeigaku ; 47(8): 491-6, 2007 Aug.
Article in Japanese | MEDLINE | ID: mdl-17882940

ABSTRACT

We investigated trends in neurological complications of infection with human immunodeficiency virus (HIV) in Japan after the introduction of highly active antiretroviral therapy (HAART). Two questionnaire surveys were performed in hospitals treating acquired immunodeficiency syndrome (AIDS) to compare two periods: immediately after the introduction of HAART (1999-2001); and a few years later (2002-3). Neurological complications accompanied 15.9% in 1999-2001 and 9.8% in 2002-3. Neurological complications developed without HAART in about 80% of cases. Neurological complications developed as the first AIDS-defining disease for 8.3% of AIDS patients in 1999-2001 and for 5.4% in 2002-3. Prevalences of HIV encephalopathy and myelopathy decreased markedly over the study period, as reported in other developed nations. However, prevalences of cytomegalovirus encephalitis, PML and primary brain lymphoma did not decrease. PML and primary brain lymphoma occurred in patients who received HAART and whose CD4 counts were relatively high during the study period. This is probably related to the extended survival of HIV-infected individuals after the introduction of HAART as a worldwide therapy, and the reactivation of viremia or latent infection persisting within the central nervous system.


Subject(s)
Acquired Immunodeficiency Syndrome/complications , Acquired Immunodeficiency Syndrome/drug therapy , Antiretroviral Therapy, Highly Active , Central Nervous System Diseases/epidemiology , AIDS Arteritis, Central Nervous System/epidemiology , AIDS-Associated Nephropathy/epidemiology , AIDS-Related Complex/epidemiology , Humans , Japan/epidemiology , Prevalence , Surveys and Questionnaires
8.
Voen Med Zh ; 326(1): 47-52, 80, 2005 Jan.
Article in Russian | MEDLINE | ID: mdl-15754771

ABSTRACT

HIV-infection in Russia and its Armed Forces is a serious threat to the national health and country's safety. Study of peculiarities of disease spread in the military collectives and HIV-infection manifestation is an actual problem. HIV-infection is diagnosed during the latent stage in all categories of servicemen and characterized by unchanged function of cellular and humoral immunity. In most servicemen with HIV-infection the disease course has a form of co-infection with parenteral hepatitis B and C.


Subject(s)
HIV Infections , Military Personnel , AIDS-Related Complex/epidemiology , AIDS-Related Complex/etiology , Adult , Antibody Formation/immunology , HIV Infections/complications , HIV Infections/diagnosis , HIV Infections/epidemiology , HIV Infections/immunology , Hepatitis, Viral, Human/complications , Hepatitis, Viral, Human/epidemiology , Humans , Immunity, Cellular/immunology , Medical Records , Military Personnel/statistics & numerical data , Retrospective Studies , Russia/epidemiology , Severity of Illness Index
9.
Int J STD AIDS ; 12(9): 573-81, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11516366

ABSTRACT

Our objective was to assess, in the clinical setting, the predictors of immune reconstitution (IR) and its relation with long-term clinical benefit, in HIV patients with advanced disease after highly active antiretroviral therapy (HAART) through an observational study. A retrospective cohort study in a clinical setting of 383 consecutive adult patients with advanced HIV infection (CD4+ cells <200/mm(3) at baseline), starting their first protease inhibitor (PI)-containing regimen was observed. Immune reconstitution was defined as CD4 count >200 cells/mm(3) and an increase > or =100 cells from baseline, anytime since starting HAART. Clinical benefit was defined as decreased mortality and reduction in AIDS-defining events, AIDS-related complex (ARC) events, major infections and hospitalization (days spent in hospital). During a mean follow-up of 808 days, 261 patients (68.1%) achieved IR. About 50% of these patients reached this result within one year after starting HAART. In multivariate analysis, predictors of immune recovery were sex (female) and baseline CD4 count higher than 50 cells/mm(3). The group of patients with IR had greater clinical benefit with lower mortality, fewer AIDS-defining events, shorter lengths of stay in hospital, fewer ARC events and fewer major infections during all the follow-up (P < 0.0001, tests for trends). However, although they did less remarkably than the first group of patients, even those patients who did not achieve IR experienced a significant decrease in the incidence of all the above events, as compared with the first and sometimes the second trimester after starting their HIV therapy. About 70% of HIV patients with advanced disease achieved IR after starting HAART. Such a benefit is a time-dependent effect and may even take more than 2 years to occur. Predictors of IR were sex (female) and higher baseline CD4 count (>50 cells/mm(3)). The patients who achieved immune recovery performed clinically better than patients who did not. Also the patients who failed to gain such a strong immunological recovery experienced a long-term clinical benefit. This suggests that PI-containing regimens, in advanced HIV disease, may produce a significant clinical benefit, at least temporary, even for patients who do not achieve a substantial immune response.


Subject(s)
Anti-HIV Agents/therapeutic use , Antiretroviral Therapy, Highly Active , HIV Infections/drug therapy , HIV-1 , AIDS-Related Complex/epidemiology , AIDS-Related Opportunistic Infections/epidemiology , Acquired Immunodeficiency Syndrome/drug therapy , Acquired Immunodeficiency Syndrome/epidemiology , Adult , CD4 Lymphocyte Count , Cohort Studies , Disease Progression , Drug Therapy, Combination , Female , HIV Infections/immunology , HIV Infections/mortality , HIV Protease Inhibitors/therapeutic use , Humans , Incidence , Male , Retrospective Studies , Treatment Outcome
10.
Int J Tuberc Lung Dis ; 5(8): 703-6, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11495259

ABSTRACT

SETTING: Bugando Medical Centre, a referral consultant hospital in the lake zone to which all inmates from Butimba prison are admitted and treated. OBJECTIVE: To determine the extent of open (smear-positive) tuberculosis and other types of tuberculosis among prisoners with tuberculosis. DESIGN: A retrospective cohort study. Case notes of 501 prisoners from January 1994 to December 1997 were retrieved and reviewed. RESULTS: The proportion of open tuberculosis in this study was high, with 204 prisoners (40.7%) having smear-positive tuberculosis. Co-infection was recorded in the majority of patients; HIV/AIDS was recorded in 25.9% of cases. The mean length of imprisonment at the time of diagnosis was 19 months. CONCLUSION: The proportion of open, smear-positive tuberculosis among prisoners admitted with tuberculosis is high. Intervention measures specifically targeting this population are urgently needed in order to contain tuberculosis disease in the prison population.


Subject(s)
AIDS-Related Complex/epidemiology , Prisons , Tuberculosis/epidemiology , Adolescent , Adult , Aged , Avitaminosis/epidemiology , Cohort Studies , Diarrhea/epidemiology , Female , Humans , Male , Medical Records/statistics & numerical data , Middle Aged , Nutrition Disorders/epidemiology , Retrospective Studies , Scabies/epidemiology , Sputum/microbiology , Tanzania/epidemiology , Time Factors
11.
Mem Inst Oswaldo Cruz ; 95(4): 437-43, 2000.
Article in English | MEDLINE | ID: mdl-10904397

ABSTRACT

The objective of this study was to identify tuberculosis risk factors and possible surrogate markers among human immunodeficiency virus (HIV)-infected persons. A retrospective case-control study was carried out at the HIV outpatient clinic of the Universidade Federal de Minas Gerais in Belo Horizonte. We reviewed the demographic, social-economical and medical data of 477 HIV-infected individuals evaluated from 1985 to 1996. The variables were submitted to an univariate and stratified analysis. Aids related complex (ARC), past history of pneumonia, past history of hospitalization, CD4 count and no antiretroviral use were identified as possible effect modifiers and confounding variables, and were submitted to logistic regression analysis by the stepwise method. ARC had an odds ratio (OR) of 3.5 (CI 95% - 1.2-10.8) for tuberculosis development. Past history of pneumonia (OR 1.7 - CI 95% 0.6-5.2) and the CD4 count (OR 0.4 - CI 0. 2-1.2) had no statistical significance. These results show that ARC is an important clinical surrogate for tuberculosis in HIV-infected patients. Despite the need of confirmation in future studies, these results suggest that the ideal moment for tuberculosis chemoprophylaxis could be previous to the introduction of antiretroviral treatment or even just after the diagnosis of HIV infection.


Subject(s)
AIDS-Related Complex/epidemiology , AIDS-Related Opportunistic Infections/epidemiology , Tuberculosis, Pulmonary/epidemiology , AIDS-Related Complex/diagnosis , Adolescent , Adult , Bias , Biomarkers , Brazil/epidemiology , Case-Control Studies , Confidence Intervals , Female , Humans , Male , Middle Aged , Odds Ratio , Retrospective Studies , Risk Factors , Tuberculosis, Pulmonary/etiology , Tuberculosis, Pulmonary/prevention & control
12.
Mem. Inst. Oswaldo Cruz ; 95(4): 437-43, July-Aug. 2000. tab
Article in English | LILACS | ID: lil-264222

ABSTRACT

The objective of this study was to identify tuberculosis risk factors and possible surrogate markers among human immunodeficiency virus (HIV)-infected persons. A retrospective case-control study was carried out at the HIV outpatient clinic of the Universidade Federal de Minas Gerais in Belo Horizonte. We reviewed the demographic, social-economical and medical data of 477 HIV-infected individuals evaluated from 1985 to 1996. The variables were submitted to an univariate and stratified analysis. Aids related complex (ARC), past history of pneumonia, past history of hospitalization, CD4 count and no antiretroviral use were identified as possible effect modifiers and confounding variables, and were submitted to logistic regression analysis by the stepwise method. ARC had an odds ratio (OR) of 3.5 (CI 95 per cent - 1.2-10.8) for tuberculosis development. Past history of pneumonia (OR 1.7 - CI 95 0.6-5.2) and the CD4 count (OR 0.4 - CI 0.2-1.2) had no statistical significance. These results show that ARC is an important clinical surrogate for tuberculosis in HIV-infected patients. Despite the need of confirmation in future studies, these results suggest that the ideal moment for tuberculosis chemoprophylaxis could be previous to the introduction of antiretroviral treatment or even just after the diagnosis of HIV infection.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , AIDS-Related Complex/epidemiology , AIDS-Related Opportunistic Infections/epidemiology , Tuberculosis, Pulmonary/epidemiology , AIDS-Related Complex/diagnosis , Bias , Biomarkers , Brazil/epidemiology , Case-Control Studies , Confidence Intervals , HIV Infections/complications , Hospitalization , Odds Ratio , Retrospective Studies , Risk Factors , Tuberculosis, Pulmonary/etiology , Tuberculosis, Pulmonary/prevention & control
13.
AIDS Res Hum Retroviruses ; 16(7): 613-9, 2000 May 01.
Article in English | MEDLINE | ID: mdl-10791871

ABSTRACT

To assess the molecular epidemiology of HIV-1 in Republic of Congo (Congo), we investigated 29 HIV-1s obtained from 82 Congolese AIDS and ARC patients in 1996 and 1997. Part of the env region including the V3 loop was phylogenetically analyzed. The genotypes observed were varied: of 29 specimens, 12 (41 %) were subtype A, 1 (3%) was subtype D, 6 (21%) were subtype G, 6 (21%) were subtype H, 2 (7%) were subtype J, and 2 (7%) could not be classified as any known subtypes (U, unclassified). The heterogeneous profile of HIV-1 infection was different from the profiles of neighboring Central African countries. These data show that subtypes G and H as well as subtype A were circulating with high prevalence. The fact that new genetic subtypes (J and U) are circulating indicates a need for a greater surveillance for these subtypes both in Congo as well as in other parts of the world.


Subject(s)
AIDS-Related Complex/virology , Acquired Immunodeficiency Syndrome/virology , HIV-1/classification , HIV-1/genetics , AIDS-Related Complex/epidemiology , Acquired Immunodeficiency Syndrome/epidemiology , Adult , Amino Acid Sequence , Congo/epidemiology , Female , HIV Envelope Protein gp120/genetics , Humans , Male , Molecular Epidemiology , Molecular Sequence Data , Peptide Fragments/genetics , Phylogeny , Polymerase Chain Reaction , Sequence Analysis, DNA
14.
Acta Virol ; 41(1): 51-4, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9199716

ABSTRACT

Eleven human immunodeficiency virus 1 (HIV-1) isolates from Ghanaian acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) patients obtained by our serosurvey in 1986-1994 were genomically analyzed and phylogenetically compared with other known strains. A phylogenetic tree constructed by analyzing the env region indicated that heterogeneous HIV-1 strains were circulating in Ghana and the majority of them (9 of 11 isolates) belonged to clade (subtype) A which is now furiously epidemic in Africa. Another isolate (1 of 11) belonged to clade D, and the remaining one (1 of 11) belonged to "clade G". This "clade G" virus grouped by the env analysis belonged to clade A by its pol sequence, suggesting an A/G intersubtype recombinant. The characteristic sequences in the V3 tip which have not yet been reported were observed in these Ghanaian isolates, which should be taken into account for future vaccine programs.


PIP: The molecular epidemiology of HIV-1 in Ghana was investigated through genomic and phylogenetic analysis of isolates from 11 AIDS or AIDS-related complex patients obtained in 1986-94. A phylogenetic tree constructed by analyzing the env region indicated that heterogeneous HIV-1 strains are circulating in Ghana. 9 of the isolates belonged to clade A, 1 to subtype D, and 1 to "clade G"--an A/G intersubtype recombinant. The V3 loops of all isolates were composed of 35 amino acid residues--a characteristic not previously described. These molecular data on the genetic variability of the envelope glycoprotein of HIV-1 should be useful for future vaccine studies in West Africa.


Subject(s)
HIV-1/classification , HIV-1/genetics , Phylogeny , AIDS-Related Complex/epidemiology , AIDS-Related Complex/virology , Acquired Immunodeficiency Syndrome/epidemiology , Acquired Immunodeficiency Syndrome/virology , Amino Acid Sequence , Base Sequence , Consensus Sequence , DNA Primers/genetics , Disease Outbreaks , Genes, env , Genes, pol , Ghana/epidemiology , HIV Envelope Protein gp120/genetics , HIV-1/isolation & purification , Humans , Molecular Epidemiology , Molecular Sequence Data , Peptide Fragments/genetics , Recombination, Genetic , Sequence Homology, Amino Acid
15.
East Afr Med J ; 74(1): 17-20, 1997 Jan.
Article in English | MEDLINE | ID: mdl-9145571

ABSTRACT

We determined the prevalence of HIV among AIDS and AIDS-Related Complex (ARC) patients seen within one year in two hospitals in southern Ghana. Subjects were screened by an ELISA procedure for anti-HIV antibodies. Specific identification of the HIV type was done with a particle agglutination (PA) kit. All PA-determined dual specimens were then confirmed by Western blotting and Pepti-Lav 1/2 monoepitope kit. Virus isolation was attempted from symptomatic patients by co-culturing patient peripheral blood monocyte cells (PBMCs) and CD4+ cell lines. PBMCs and HIV isolates were characterised by PCR. By ELISA, 43.5% of the subjects (253) had anti-HIV antibodies. Of these, 61 (24%) were HIV-1 positive and 42 (18.6%) were dually reactive by PA. However, only 19% were confirmed as true dually-infected cases by western blotting and Pepti-Lav through all 42 samples were HIV-1 positive on the two tests. No subject was infected with HIV-2 alone. Three viruses were isolated. By PCR two of them had both HIV-1 and HIV-2 proviral sequences while the third virus was HIV-1 only. HIV-1 prevalence now predominates over HIV-2 implying a switch in the HIV infection pattern in Ghana. Furthermore mixed infections exist. The predominance of HIV-1 infection in Ghana may indicate a similar trend in other parts of West Africa.


PIP: Recent studies have suggested that HIV-2 infection is becoming less prevalent in Ghana, while the prevalence of HIV-1 is increasing. To confirm such a modification in the HIV infection profile in Ghana, a 1-year serologic and molecular study was conducted among 253 patients from 2 hospitals in southern Ghana (Accra and Dzodze in the Volta region) with confirmed or suspected AIDS. All 253 serum specimens were screened with enzyme-linked immunosorbent assay (ELISA) and particle agglutination (PA); the 42 dually reactive specimens were subsequently confirmed by Western blot and Pepti-Lav tests. By ELISA, 110 samples (43.5%) were positive for anti-HIV antibodies; this rate was 39.2% in Accra and 81.0% in the Volta region. Of these, 61 (24.1%) were HIV-1 positive and 42 (18.6%) were dually reactive by PA. No case of HIV-2 alone was detected. Most dually reactive cases were a cross-reaction between genetically similar regions of the 2 HIV types. Only 19% of the 42 PA-diagnosed dually reactive specimens were confirmed by Western blot and Pepti-Lav as true cases of HIV-2 only infection, and all these specimens were strongly positive for anti-HIV-1 antibodies. 3 viruses were isolated. By polymerase chain reaction, 2 had both HIV-1 and HIV-2 proviral sequences, while the third was HIV-1 only. This study's findings provide support for the hypothesis that most individuals with antibodies to both HIV-1 and HIV-2 are probably infected with HIV-1 alone. Intensified population surveillance aimed at isolating more HIV strains in West Africa could reveal the true extent of HIV genomic variation and facilitate the design of more specific diagnostic kits.


Subject(s)
AIDS-Related Complex/virology , Acquired Immunodeficiency Syndrome/virology , HIV Seroprevalence , HIV-1 , HIV-2 , AIDS-Related Complex/epidemiology , Acquired Immunodeficiency Syndrome/epidemiology , Case-Control Studies , Comorbidity , Ghana/epidemiology , HIV-1/genetics , HIV-2/genetics , Humans , Mass Screening
16.
Trop Doct ; 26(2): 58-61, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8685966

ABSTRACT

In order to assess the effect of the HIV epidemic on lymph node biopsies in Central Africa, HIV-1 serology was tested on a cohort of patients undergoing node biopsy in Lusaka in 1990, and the histology of all lymph nodes biopsied in Lusaka in 1981 and 1990 was reviewed. One hundred and eighteen lymph nodes were biopsied in 1981 and 351 in 1990. Cases of tuberculous lymphadenitis increased from 52 (31 children and 21 adults) in 1981 to 186 (22 children, 160 adults, four patients unknown age) in 1990. Sixty-eight of 77 adults (88%) with tuberculous lymphadenitis in 1990 tested HIV-positive. Cases of histology suspicious of primary HIV lymphadenopathy and nodal Kaposi's disease also increased. Cases of malignant lymphadenopathy and overall number of surgical biopsies remained equivalent for 1981 and 1990. The study concludes that the HIV epidemic has led to a large increase in diagnostic lymph node biopsies in Lusaka, mostly through an increase in HIV-related adult tuberculous lymphadenitis.


Subject(s)
HIV Infections/complications , Lymph Node Excision/statistics & numerical data , Tuberculosis, Lymph Node/epidemiology , AIDS-Related Complex/diagnosis , AIDS-Related Complex/epidemiology , Adolescent , Adult , Age Distribution , Aged , Child , Child, Preschool , Female , Humans , Infant , Male , Middle Aged , Sex Distribution , Tuberculosis, Lymph Node/complications , Tuberculosis, Lymph Node/diagnosis , Zambia/epidemiology
18.
Br J Surg ; 83(1): 75-8, 1996 Jan.
Article in English | MEDLINE | ID: mdl-8653372

ABSTRACT

The relative importance of human immunodeficiency virus (HIV)-associated lymphadenopathy amongst patients presenting for lymph node biopsy in Central Africa is unknown. HIV-1 serology and histology of patients undergoing superficial lymph node biopsy during 1989-1990 in Lusaka, Zambia, were examined in a prospective cohort study of HIV serology and by retrospective review of laboratory records. Of 727 lymph nodes biopsied in Lusaka in 1989-1990, 380 (52 per cent) showed tuberculous lymphadenitis, 160 (22 per cent) histology suggestive of primary HIV lymphadenopathy and 66 (9 per cent) nodal Kaposi's disease. HIV serology was tested in 280 adults and was positive in 91 per cent (255 patients), including 89 per cent (153 of 171) of those with tuberculous lymphadenitis, 98 per cent (63 of 64) of those with histology suspicious of primary HIV lymphadenopathy and all (24 of 24) with nodal Kaposi's disease. Other HIV-associated lymphadenopathy included nodal lymphomas and lymphoepithelial cysts. HIV serology was tested in 22 children and was positive in eight, including four of 14 with tuberculous lymphadenitis. It is concluded that HIV-associated lymphadenopathy, especially tuberculous lymphadenitis, is very common amongst patients presenting for lymph node biopsy in Central Africa.


PIP: Data from a prospective cohort study conducted during 1989-1990 of HIV serology and from a retrospective review of laboratory records of 727 patients presenting for superficial lymph node biopsy at the University Teaching Hospital in Lusaka, Zambia, were analyzed to determine the relative significance of HIV-associated lymphadenopathy among patients undergoing lymph node biopsy. 380 (52%) of the 727 biopsy patients had tuberculous lymphadenitis (secondary HIV lymphadenopathy). Another 160 (22%) had presumed primary HIV lymphadenopathy. The remaining 66 (9%) had nodal Kaposi's disease. 280 adults were tested for HIV antibodies. 91% tested positive for HIV. The HIV rate was 89% for patients with tuberculous lymphadenitis, 98% for suspected primary HIV lymphadenopathy cases, and 100% for those with nodal Kaposi's disease. As for the 22 children 0-16 years old, 8 were HIV positive. 50% of HIV-positive children who underwent lymph node biopsy had tuberculous lymphadenitis. Three had suspected primary HIV lymphadenopathy and 1 had nodal Kaposi's disease. These findings show that HIV-associated lymphadenopathy, particularly tuberculous lymphadenitis, is very prevalent in patients undergoing lymph node biopsy. They stress the importance of investigating further HIV-positive patients with suspicious asymmetrical nodes in central Africa. Simple, appropriate methods (e.g., wide-needle aspiration) are needed for the diagnosis of tuberculous lymphadenitis in this region, with its dearth of facilities for surgery and histopathology.


Subject(s)
AIDS-Related Complex/epidemiology , AIDS-Related Opportunistic Infections/epidemiology , Tuberculosis, Lymph Node/epidemiology , AIDS-Related Complex/complications , AIDS-Related Complex/pathology , AIDS-Related Opportunistic Infections/complications , AIDS-Related Opportunistic Infections/pathology , Adolescent , Adult , Age Distribution , Biopsy, Needle , Child , Child, Preschool , Cohort Studies , Female , HIV Seropositivity , Humans , Incidence , Infant , Infant, Newborn , Male , Middle Aged , Mycobacterium tuberculosis/isolation & purification , Retrospective Studies , Sex Distribution , Tuberculosis, Lymph Node/complications , Tuberculosis, Lymph Node/pathology , Zambia/epidemiology
19.
Rev. sanid. mil ; 49(5): 135-6, sept.-oct. 1995.
Article in Spanish | LILACS | ID: lil-173847

ABSTRACT

El linforma no Hodgkin es una neoplasia relacionada con el SIDA, cuya incidencia se incrementa a mayor duración de la infección por el VIH. Se presenta el caso de un hombre de 21 años de edad con diagnóstico de linfoma no Hodgkin inmunoblástico de células grandes, primario del yeyuno


Subject(s)
Adult , Humans , Male , Lymphoma, Non-Hodgkin/diagnosis , HIV Infections/complications , AIDS-Related Complex/epidemiology , Intestinal Neoplasms/etiology , Jejunal Neoplasms/surgery , Acquired Immunodeficiency Syndrome/complications
20.
AIDS Res Hum Retroviruses ; 11(2): 319-21, 1995 Feb.
Article in English | MEDLINE | ID: mdl-7742046

ABSTRACT

We have used a particle agglutination (PA) test, Western blot (WB) test, polymerase chain reaction (PCR) test, and virus isolation to define the human immunodeficiency virus (HIV) status of 17 acquired immunodeficiency syndrome (AIDS), 6 AIDS-related complex (ARC), and 2 asymptomatic Ghanaians. HIV-1 antibodies were more frequently detected. The PCR detected 66.7% HIV-1, 11.1% HIV-2, and 5.6% of both HIV-1 and HIV-2 proviral DNA in peripheral blood mononuclear cell (PBMCs) and PBMC-Molt 4 coculture samples tested. Of the 12 viruses isolated from the 25 Ghanaians, 9 were HIV-1, 2 were HIV-2, and both HIV-1 and HIV-2 were isolated from 1 individual. Two of the HIV-1 isolates were from ARC patients who have been PA negative and either HIV-1 or HIV-2 WB indeterminate for more than 1 year without developing antibodies to HIV envelope proteins. Our results indicate that HIV-1 is now predominant in Ghanaian AIDS and ARC patients and that dual infection can occur.


PIP: While HIV is believed to be the causative agent for AIDS, many clinically diagnosed AIDS and AIDS-related complex (ARC) cases in Ghana have been reported to be negative or indeterminate for HIV antibodies. Dual seropositive reactions have also been common among AIDS and ARC cases in the country. A particle agglutination (PA) test, Western blot (WB), polymerase chain reaction (PCR), and virus isolation were used to define the HIV status of 17 AIDS, 6 ARC, and 2 asymptomatic Ghanaians. The PA test detected HIV-1 antibodies in 72% of the plasma samples, 94.4% of which were also positive according to WB. 1 sample was indeterminate by WB and 2 HIV-1 negative samples were determined to be positive by WB. HIV-2 was detected by PA in 32% of all samples, of which 87.5% were confirmed by WB. PCR detected 66.7% of HIV-1 cases, 11.1% of HIV-2, and 5.6% of both HIV-1 and HIV-2 proviral DNA in peripheral blood mononuclear cells (PBMCs) and PBMC-Molt 4 coculture samples tested. 12 viruses were isolated from the 25 subjects; 9 were identified as HIV-1, 2 as HIV-2, and 1 person was infected with both HIV-1 and HIV-2. 2 of the HIV-1 isolates were from ARC patients who had been PA-negative and either HIV-1 or HIV-2 WB indeterminate for more than 1 year without developing antibodies to HIV envelope proteins.


Subject(s)
AIDS-Related Complex/virology , Acquired Immunodeficiency Syndrome/virology , HIV-1/isolation & purification , HIV-2/isolation & purification , AIDS-Related Complex/epidemiology , Acquired Immunodeficiency Syndrome/epidemiology , Agglutination Tests , Base Sequence , Blotting, Western , DNA Primers , Ghana/epidemiology , Humans , Molecular Sequence Data , Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL
...